Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-09 Sale |
2023-02-13 7:58 pm |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
5,000 | $53.76 | $268,816 | 83,463 (Direct) |
View |
| 2022-12-16 Sale |
2022-12-16 9:44 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
30,000 | $44.72 | $1,341,713 | 801,717 (Direct) |
View |
| 2022-04-01 Sale |
2022-04-05 7:54 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
83,344 | $71.6 | $5,967,688 | 75,567 (Direct) |
View |
| 2022-03-21 Sale |
2022-03-22 5:52 pm |
ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director |
6,000 | $67.83 | $406,970 | 0 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-03 6:02 pm |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
36,820 | $70.2 | $2,584,682 | 47,463 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-02 Option Award |
2023-03-06 5:16 pm |
N/A 2033-03-02 |
ENANTA PHARMACEUTICALS INC | ENTA | FOLETTA MARK G Director |
10,800 | $0 | 10,800 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 5:15 pm |
N/A 2033-03-02 |
ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director |
10,800 | $0 | 10,800 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 9:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. |
20,305 | $0 | 39,614 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 9:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. |
6,416 | $52.77 | 39,614 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 9:51 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
20,997 | $0 | 40,138 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 9:51 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
6,725 | $52.77 | 40,138 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 9:49 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Sr. VP & General Counsel |
20,997 | $0 | 101,420 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 9:49 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Sr. VP & General Counsel |
6,735 | $52.77 | 101,420 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 9:46 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Sr. VP & CSO |
23,267 | $0 | 374,702 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 9:46 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Sr. VP & CSO |
7,752 | $52.77 | 374,702 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 9:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
20,997 | $0 | 97,556 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 9:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
6,904 | $52.77 | 97,556 (Direct) |
View |
| 2023-02-13 Option Award(A) |
2023-02-15 9:42 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
52,096 | $0 | 819,810 (Direct) |
View |
| 2023-02-13 Tax Withholding(A) |
2023-02-15 9:42 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
20,591 | $52.77 | 819,810 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 8:56 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
31,505 | $0 | 799,219 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 8:56 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
20,591 | $52.77 | 799,219 (Direct) |
View |
| 2023-01-09 Exercise |
2023-01-10 7:11 pm |
N/A 2023-01-17 |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
2,812 | $0 | 88,463 (Direct) |
View |
| 2023-01-09 Exercise |
2023-01-10 7:11 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
2,812 | $14.18 | 88,463 (Direct) |
View |
| 2022-12-19 Exercise |
2022-12-19 7:53 pm |
N/A 2022-12-26 |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
4,148 | $0 | 85,651 (Direct) |
View |
| 2022-12-19 Exercise |
2022-12-19 7:53 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
4,148 | $14.18 | 85,651 (Direct) |
View |
| 2022-12-19 Exercise |
2022-12-19 7:50 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
14,500 | $27.58 | 843,805 (Direct) |
View |
| 2022-12-19 Exercise |
2022-12-19 7:50 pm |
N/A 2023-12-05 |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
14,500 | $0 | 843,805 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-16 9:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
13,851 | $14 | 801,717 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-16 9:44 pm |
N/A 2022-12-26 |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
30,000 | $0 | 801,717 (Direct) |
View |
| 2022-12-16 Exercise |
2022-12-16 9:44 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
16,149 | $14.18 | 801,717 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 7:30 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. |
498 | $44.33 | 25,725 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 7:27 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
498 | $44.33 | 25,866 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 7:25 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Sr. VP & General Counsel |
1,055 | $44.33 | 87,158 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 7:22 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Sr. VP & CSO |
1,055 | $44.33 | 359,187 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 7:20 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
1,055 | $44.33 | 81,503 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-05 7:17 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
5,659 | $44.33 | 773,805 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:41 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. |
58,500 | $0 | 66,223 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:38 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Kieffer Tara Lynn Sr. VP, New Product Dev. |
58,500 | $0 | 66,364 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:34 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Gardiner Nathaniel S. Sr. VP & General Counsel |
66,000 | $0 | 133,213 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:28 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
22,000 | $0 | 42,000 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:23 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Or Yat Sun Sr. VP & CSO |
66,000 | $0 | 405,242 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:20 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
66,000 | $0 | 127,558 (Direct) |
View |
| 2022-11-23 Option Award |
2022-11-28 6:17 pm |
N/A 2032-11-23 |
ENANTA PHARMACEUTICALS INC | ENTA | Luly Jay R. President and CEO |
197,000 | $0 | 913,464 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-11 4:32 pm |
N/A 2032-08-08 |
ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer |
95,000 | $0 | 95,000 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-21 4:01 pm |
N/A 2022-06-20 |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
3,480 | $0 | 61,558 (Direct) |
View |
| 2022-06-17 Exercise |
2022-06-21 4:01 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | MELLETT PAUL J Treasurer and CFO |
3,480 | $11.77 | 61,558 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
16,000 | $31.42 | 75,567 (Direct) |
View |
| 2022-04-04 Exercise |
2022-04-05 7:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
16,875 | $63.35 | 75,567 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
31,664 | $30 | 75,567 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:54 pm |
N/A 2025-11-20 |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
83,344 | $0 | 75,567 (Direct) |
View |
| 2022-04-01 Exercise |
2022-04-05 7:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
9,180 | $48.52 | 75,567 (Direct) |
View |
| 2022-04-04 Exercise |
2022-04-05 7:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
9,625 | $43.57 | 75,567 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-22 5:52 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director |
6,000 | $25.58 | 0 (Direct) |
View |
| 2022-03-21 Exercise |
2022-03-22 5:52 pm |
N/A 2026-02-11 |
ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director |
6,000 | $0 | 0 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:52 pm |
N/A 2032-03-03 |
ENANTA PHARMACEUTICALS INC | ENTA | Vance Terry Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:50 pm |
N/A 2032-03-03 |
ENANTA PHARMACEUTICALS INC | ENTA | Russell Lesley Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:46 pm |
N/A 2032-03-03 |
ENANTA PHARMACEUTICALS INC | ENTA | Peterson Kristine Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:45 pm |
N/A 2032-03-03 |
ENANTA PHARMACEUTICALS INC | ENTA | Hata Yujiro S Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:42 pm |
N/A 2032-03-03 |
ENANTA PHARMACEUTICALS INC | ENTA | FOLETTA MARK G Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-07 6:40 pm |
N/A 2032-03-03 |
ENANTA PHARMACEUTICALS INC | ENTA | CARTER BRUCE L A Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 6:02 pm |
N/A 2025-06-29 |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
36,820 | $0 | 47,463 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-03 6:02 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Adda Nathalie Sr. VP & Chief Medical Officer |
36,820 | $43.46 | 47,463 (Direct) |
View |
| 2022-02-14 Option Award |
2022-02-15 9:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. |
1,412 | $0 | 7,723 (Direct) |
View |
| 2022-02-14 Tax Withholding |
2022-02-15 9:54 pm |
N/A N/A |
ENANTA PHARMACEUTICALS INC | ENTA | Luu Brendan Sr. VP, Business Dev. |
489 | $62.49 | 7,723 (Direct) |
View |